Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.4100
-0.0400 (-8.89%)
Apr 1, 2025, 4:00 PM EST - Market closed

Lineage Cell Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-18.61-21.49-26.27-43.02-20.65
Upgrade
Depreciation & Amortization
0.610.690.730.872.11
Upgrade
Loss (Gain) From Sale of Assets
---0.010.02-0.02
Upgrade
Loss (Gain) From Sale of Investments
-0.22-0.51.69-3.73-0.78
Upgrade
Stock-Based Compensation
5.084.644.293.722.35
Upgrade
Other Operating Activities
-1.21-1.112.01-2.28-4.03
Upgrade
Change in Accounts Receivable
0.11-0.4550.31-0.860.29
Upgrade
Change in Accounts Payable
-1.68-2.3-18.721.650.31
Upgrade
Change in Unearned Revenue
-7.68-7.65-13.350.380.13
Upgrade
Change in Other Net Operating Assets
0.49-0.420.45-0.070.57
Upgrade
Operating Cash Flow
-23.09-28.571.06-23.56-19.75
Upgrade
Capital Expenditures
-0.57-0.67-0.41-0.34-0.06
Upgrade
Sale of Property, Plant & Equipment
----0.02
Upgrade
Divestitures
---0.022.12
Upgrade
Investment in Securities
-1.7447.12-45.7510.0610.94
Upgrade
Other Investing Activities
----0.02
Upgrade
Investing Cash Flow
-2.3146.45-46.169.7513.04
Upgrade
Short-Term Debt Issued
----0.52
Upgrade
Total Debt Issued
----0.52
Upgrade
Long-Term Debt Repaid
-0.05-0.05-0.03-0.02-0.03
Upgrade
Net Debt Issued (Repaid)
-0.05-0.05-0.03-0.020.5
Upgrade
Issuance of Common Stock
36.116.510.838.115.13
Upgrade
Repurchase of Common Stock
-0.02-0.04-0.02-0.05-0.03
Upgrade
Other Financing Activities
-0.17-0.89-1.124.27
Upgrade
Financing Cash Flow
35.866.421.6336.9329.87
Upgrade
Foreign Exchange Rate Adjustments
-0.1-0.25-0.87-0.02-0.06
Upgrade
Net Cash Flow
10.3624.06-44.3423.0923.09
Upgrade
Free Cash Flow
-23.66-29.240.65-23.9-19.82
Upgrade
Free Cash Flow Margin
-249.05%-326.89%4.39%-550.59%-1085.27%
Upgrade
Free Cash Flow Per Share
-0.12-0.170.00-0.14-0.13
Upgrade
Cash Interest Paid
0.010.010.010.010.02
Upgrade
Levered Free Cash Flow
-12.8-10.3713.34-37.4613.44
Upgrade
Unlevered Free Cash Flow
-12.8-10.3713.34-37.4613.44
Upgrade
Change in Net Working Capital
4.51.78-22.8110.95-25.58
Upgrade
Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q